A strong connection between PP, RyR1 channels and mitochondria is suggested by the fact that RyR1 and mitochondrial mutations have been reported to exhibit an atypical periodic paralysis phenotype (65, 66) and coenzyme Q10, an electron carrier between respiratory chain enzymes, was effective in treating PP (67). Here, RYR1 is linked to periodic paralysis.